What Supernus Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 20 |
| Total trades | 20 | 108 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 35,999 | 329,294 |
| Disposed | 2,532,158 | 2,782,269 |
| Net activity | −2,496,159 | −2,452,975 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Khattar Jack A. | President, CEO | Nov 02 | Other Transaction · J | −958,100 | — | — | 0 |
| Khattar Jack A. | President, CEO | Nov 02 | Other Transaction · J | −1,258,351 | — | — | 0 |
| Dec Timothy C | Senior Vice-President & CFO | Nov 02 | Other Transaction · J | −9,129 | — | — | 0 |
| Hudson Frederick M. | Director | Nov 02 | Other Transaction · J | −60,413 | — | — | 0 |
| Bhatt Padmanabh P. | Sr. VP of IP, CSO | Nov 02 | Other Transaction · J | −18,637 | — | — | 0 |
| Gemayel Georges | Director | Nov 02 | Other Transaction · J | −27,277 | — | — | 0 |
| Newhall Charles W Iii | Director | Nov 02 | Other Transaction · J | −124,119 | — | — | 0 |
| Rubin Jonathan | SVP, Chief Medical Officer | Nov 02 | Other Transaction · J | −13,979 | — | — | 0 |
| Mottola Frank | SVP, Chief Tech. Ops. Officer | Nov 02 | Other Transaction · J | −19,544 | — | — | 0 |
| Barlow Carrolee | Director | Nov 02 | Other Transaction · J | −27,045 | — | — | 0 |
| Bhatt Padmanabh P. | Sr. VP of IP, CSO | Aug 12 | Withheld — tax / exercise cost · F | −1,158 | $46.57 | −$53.9K | 18,637 |
| Rubin Jonathan | SVP, Chief Medical Officer | Aug 12 | Withheld — tax / exercise cost · F | −363 | $46.57 | −$16.9K | 13,979 |
| Dec Timothy C | Senior Vice-President & CFO | Aug 12 | Withheld — tax / exercise cost · F | −604 | $46.57 | −$28.1K | 9,129 |
| Dec Timothy C | Senior Vice-President & CFO | Aug 12 | Exercise / conversion · M | +1,250 | — | — | 9,733 |
| Khattar Jack A. | President, CEO | Aug 12 | Withheld — tax / exercise cost · F | −12,642 | $46.57 | −$589K | 1,258,351 |
| Bhatt Padmanabh P. | Sr. VP of IP, CSO | Aug 12 | Exercise / conversion · M | +2,500 | — | — | 19,795 |
| Rubin Jonathan | SVP, Chief Medical Officer | Aug 12 | Exercise / conversion · M | +750 | — | — | 14,342 |
| Khattar Jack A. | President, CEO | Aug 12 | Exercise / conversion · M | +29,849 | — | — | 1,270,993 |
| Mottola Frank | SVP, Chief Tech. Ops. Officer | Aug 12 | Withheld — tax / exercise cost · F | −797 | $46.57 | −$37.1K | 19,544 |
| Mottola Frank | SVP, Chief Tech. Ops. Officer | Aug 12 | Exercise / conversion · M | +1,650 | — | — | 20,341 |
Loading...
